CATS - Catasys, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
14.59
-0.31 (-2.08%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close14.90
Open14.83
Bid9.95 x 900
Ask18.00 x 1100
Day's Range14.40 - 15.22
52 Week Range7.51 - 20.83
Volume97,320
Avg. Volume144,215
Market Cap241.421M
Beta (3Y Monthly)1.83
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
All
News
Press Releases
  • Business Wire

    Catasys Reports 2019 Second Quarter Financial Results

    LOS ANGELES-- -- Q2 2019 Record Revenue of $7.7 Million, Up 135% Year over Year and Up 13% from Q1 2019 Outreach Pool of Eligible Members Increases to Approximately 112,000 in August 2019, up 49% from 75,000 at March 31, 2019 Company Reiterates 2019 GAAP Revenue Guidance of $35 Million Company to Host Conference Call at 4:30 pm ET today Catasys, Inc. , a leading AI and technology-enabled healthcare ...

  • Business Wire

    Catasys Expands Partnership with Leading National Health Plan

    Catasys, Inc. (CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced the expansion of its OnTrak-A solution with a leading national health plan into six new states. It is also the first time Catasys will operate in Maryland, Delaware and Ohio, bringing the Company’s total reach to 27 states. Eligible members in Ohio, Tennessee, North Carolina and South Carolina are now able to participate in OnTrak-A, and enrollment will commence in Maryland and Delaware before the end of Q3.

  • Business Wire

    Catasys Schedules 2019 Second Quarter Financial Results Conference Call for August 14, 2019

    Catasys, Inc. , a leading AI and technology-enabled healthcare company, today announced that the Company will be releasing financial results for its second quarter ended June 30, 2019, after the closing of the stock market on Wednesday, August 14, 2019.

  • GlobeNewswire

    BriaCell Appoints Richard J. Berman to Board of Directors

    BERKELEY, Calif., and VANCOUVER, British Columbia, Aug. 12, 2019 -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage.

  • Business Wire

    Catasys to Present at the Canaccord Genuity 39th Annual Growth Conference

    Catasys, Inc. , a leading AI and technology-enabled healthcare company, today announced that Mr. Terren Peizer, the Company’s Chairman and CEO, is scheduled to present at the Canaccord Genuity 39th Annual Growth Conference on Wednesday, August 7, 2019, at 2 p.m.

  • Business Wire

    Catasys Launches Breakthrough AI Capability to Address Chronic Disease

    Catasys PRETM platform for predictive identification of care avoidant individuals with chronic disease

  • Business Wire

    Catasys Appoints Industry Veteran Rob Rebak to Board of Directors

    Catasys, Inc. , a leading AI and technology-enabled healthcare company, today announced the appointment of Mr. Robert L. Rebak to its Board of Directors, replacing Mr.

  • Business Wire

    Catasys Announces Addition to Russell 3000® and 2000® Indexes

    Catasys, Inc. (CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced that it has been added to the Russell 3000® and 2000® Indexes, effective after the U.S. markets open on Monday, July 1, 2019, as part of the 2019 Russell U.S. Indexes reconstitution. Terren Peizer, Catasys Chairman and CEO, stated, “We are very pleased to have earned our inclusion in the Russell Indexes. The annual Russell Indexes reconstitution captures the 4,000 largest US stocks at the close of the market on May 10, 2019, ranking them by total market capitalization.

  • Catasys Appoints Healthcare Executive Daniel Prewitt as Senior Vice President of Sales
    Business Wire

    Catasys Appoints Healthcare Executive Daniel Prewitt as Senior Vice President of Sales

    Catasys, Inc. , a leading AI and technology-enabled healthcare company, today announced the appointment of Daniel Prewitt as the senior vice president of sales.

  • GlobeNewswire

    Sharon R. Gabrielson Named Chair of Sharps Compliance Board of Directors

    Sharon Gabrielson joined the Sharps Compliance board in February 2019.  She is a progressive healthcare executive with over 30 years of broad-based leadership experience in the healthcare industry and currently serves as Chair of Global Business Solutions for the Mayo Clinic, where she is responsible for directing domestic and international business development opportunities for the Clinic’s healthcare products and services to the B2B and B2C markets.  Previously, Ms. Gabrielson was Vice Chair of Mayo’s Health System Administration, where she oversaw an organization of community-based practices including hospitals, clinics, nursing homes, and home health, which generated approximately $2 billion in revenues. Ms. Gabrielson has served on numerous leadership and management committees at Mayo Clinic, as well as industry boards including for-profit public and private, as well as not-for-profit and community organizations.

  • Business Wire

    Catasys Adds Canary Health to OnTrak Platform

    Partnership Expands Online Support for Members with Chronic Disease

  • Business Wire

    Catasys to Present at the B. Riley FBR Institutional Investor Conference on Wednesday, May 22, 2019

    Catasys, Inc. , a leading AI and technology-enabled healthcare company, today announced that Mr. Terren Peizer, the Company’s Chairman and Chief Executive Officer, will present at the B.

  • Business Wire

    Catasys to Provide OnTrak™ Program Free to Members in Need Throughout May to Honor Mental Health Awareness Month

    Catasys, Inc. , a leading AI and technology-enabled healthcare company, today announced that for every day in the month of May, it is sponsoring a health plan member who would otherwise not be able to participate in OnTrak, at no cost to either the member or the health plan.

  • Business Wire

    Catasys Reports 2019 First Quarter Financial Results

    LOS ANGELES-- -- Q1 2019 Record Revenue of $6.8 Million, Up 256% Year over Year and Up 21% from Q4 2018 Outreach Pool of Eligible Members Increases to Approximately 92,000 in May 2019, up 124% from 41,000 at December 31, 2018 Company Reiterates 2019 GAAP Revenue Guidance of $35 Million Company to Host Conference Call at 4:30 pm ET today Catasys, Inc. , a leading AI and technology-enabled healthcare ...

  • Business Wire

    Catasys Announces Proprietary Interventions for Treatment of Loneliness Epidemic

    Catasys, Inc. (CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced that it is expanding the use of its OnTrak solution to help identify and address loneliness. An estimated one in three adults over age 45 suffer from chronic loneliness, according to a 2018 survey by the AARP Foundation. Poor social relationships have been associated with a 29% increase in risk of coronary heart disease and a 32% rise in the risk of stroke, along with increased use of accident and emergency services independent of chronic illness.

  • Business Wire

    Catasys Announces Partnership with Circulation and Lyft

    Groundbreaking Relationship Expands Catasys’ Ability to Address Social Determinants of Health

  • Business Wire

    Catasys Expands OnTrak-C Solution with Leading National Health Plan

    Catasys, Inc. (CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced that it has expanded its OnTrak-C solution with one of the nation's leading health insurance providers. Eligible Medicaid members in Texas will now be able to participate in OnTrak for treatment of anxiety and depression, in addition to substance use disorders. OnTrak is an integrated suite of interventions for health plan members with unaddressed behavioral conditions that worsen chronic medical comorbidities.

  • Business Wire

    Catasys Schedules 2019 First Quarter Financial Results Conference Call for May 9, 2019

    Catasys, Inc. , a leading AI and technology-enabled healthcare company, today announced that the Company will be releasing financial results for its first quarter ended March 31, 2019, after the closing of the stock market on Thursday, May 9, 2019.

  • Business Wire

    Catasys Expands OnTrak-Ci Solution with Leading National Health Plan’s Eligible Medicare Advantage Members in Alabama, Mississippi and Florida

    Alabama and Mississippi represent 23rd and 24th states in which OnTrak is Available

  • Business Wire

    Catasys to Present at ThinkEquity Conference on May 2, 2019 in New York City

    Catasys, Inc. (CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced that the Company will present at the ThinkEquity Conference on Thursday, May 2, 2019 at 2:30 pm ET at the Mandarin Oriental Hotel in New York City. Catasys will also be conducting one-on-one meetings throughout the day. A live webcast of the presentation will be available in the Investors section of the Company's website, and also at http://wsw.com/webcast/thinkequity/cats/.

  • Business Wire

    Catasys Announces Agreement with Optima Health

    OnTrak™ Solution Launch Slated for Second Quarter 2019

  • Catasys Appoints Healthcare Industry Leader Carol Murdock to Newly Created Chief Commercial Officer Role
    Business Wire

    Catasys Appoints Healthcare Industry Leader Carol Murdock to Newly Created Chief Commercial Officer Role

    Catasys, Inc. (CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced the appointment of Carol Murdock as Chief Commercial Officer. Ms. Murdock joins the Company with over 30 years of healthcare experience in market strategy and business development where her managed care, technology and engagement expertise has helped customers lower cost and improve quality of care.

  • Business Wire

    Catasys Reports 2018 Fourth Quarter and Year-end Financial Results

    LOS ANGELES-- -- Q4 2018 Record Revenue of $5.6 Million, up 85.3% Year over Year and Up 28.7% from Q3 2018 YE 2018 Record Revenue of $15.2 Million, Up 96.7% from YE 2017 Outreach Pool of Eligible Members Increased to approximately 75,000 Members at March 1, 2019 as a Result of Significant Expansion within Existing Plans Reiterates 2019 GAAP Revenue Guidance of $35 Million Company to Host Conference ...

  • Business Wire

    Catasys Announces Expansion of Debt Financing Agreement to $15 Million; Proceeds to be Utilized to Support Accelerating Growth

    Catasys, Inc. (CATS), a leading AI and technology-enabled healthcare company, announced today that it has entered into an amendment and expansion of its previously announced financing of a receivable facility agreement and term loan (see: Catasys Attracts $10 Million in Debt Financing to Support Accelerating Growth - June 14, 2018). The Company entered into a $15 million financing with Horizon Technology Finance Corporation (“Horizon”) (HRZN), which includes initial term loans in the amount of $7.5 million previously funded under the original Loan Agreement entered into June 2018 and an additional up to $7.5 million loan in three revolving tranches of $2.5 million. The initial interest rate on the term loan is 9.75% and will float with Libor when north of 2% (currently 2.49%).

  • Business Wire

    Catasys to Present at Upcoming Investor Conferences

    Catasys, Inc. , a leading AI and technology-enabled healthcare company, today announced that Mr. Terren Peizer, the Company’s Chairman and CEO, is scheduled to participate in two upcoming investor conferences in March, including the 31st Annual ROTH Conference in Laguna Niguel, California and the Oppenheimer 29th Annual Healthcare Conference in New York City.